Search Results
Nov 05, 2025, 19:00 ET The World's First Gene-Editing Therapy Targeting APOC3 for Hyperlipidemia
The patient, diagnosed with chylomicronemia, had a long history of fasting triglyceride (TG) levels exceeding 12.5 mmol/L and recurrent acute pancreatitis. In the dose-escalation IIT for CS-121, his fasting TG level dropped significantly within three days after a single
More news about: CorrectSequence Therapeutics
Nov 05, 2025, 17:46 ET The Michael J. Fox Foundation for Parkinson's Research Applauds Texas Voters on Passage of Proposition 14 Securing $3 Billion for Brain Disease Research
Parkinson's and cares for loved ones who also face this disease, I've seen how powerful it is when our community comes together to push for change," said María L. De León, MD, an East Texas resident, movement disorder specialist and member of MJFF's Patient Council. "The passage of Proposition 14 proves that collective
More news about: The Michael J. Fox Foundation for Parkinson's Research
Nov 05, 2025, 16:15 ET Unisys Announces 3Q25 Results
adoption and innovation, TCV and Ex-L&S New Business TCV, the impact of new logo signings, backlog, book-to-bill(4), full-year 2025 revenue growth and profitability guidance, including constant currency revenue, Ex-L&S constant currency revenue growth, L&S revenue, non-GAAP operating
More news about: Unisys Corporation
Nov 05, 2025, 16:05 ET Jazz Pharmaceuticals Announces Third Quarter 2025 Financial Results and Updates 2025 Financial Guidance
Zepzelca and atezolizumab combination received FDA approval for 1L maintenance treatment of ES-SCLC based on positive data from the Phase 3 IMforte trial. Top-line PFS data from zanidatamab in Phase 3 1L GEA expected in 4Q25; updated intent-to-treat population for PFS to
More news about: Jazz Pharmaceuticals plc
Nov 05, 2025, 16:05 ET Jazz Pharmaceuticals Announces Third Quarter 2025 Financial Results and Updates 2025 Financial Guidance
Zepzelca and atezolizumab combination received FDA approval for 1L maintenance treatment of ES-SCLC based on positive data from the Phase 3 IMforte trial. Top-line PFS data from zanidatamab in Phase 3 1L GEA expected in 4Q25; updated intent-to-treat population for PFS to
More news about: Jazz Pharmaceuticals plc
Nov 05, 2025, 16:05 ET GFL Environmental Reports Third Quarter 2025 Results and Raises Full Year 2025 Guidance
(gain) loss on divestiture, (h) transaction costs, (i) acquisition, rebranding and other integration costs, (j) Founder/CEO remuneration, (k) other and (l) the tax impact of the foregoing. Adjusted income (loss) per share from continuing operations is defined as Adjusted Net Income (Loss) from continuing
More news about: GFL Environmental Inc.
Nov 05, 2025, 16:01 ET PTC ANNOUNCES FOURTH FISCAL QUARTER AND FULL FISCAL YEAR 2025 RESULTS
$150 million. GAAP and non-GAAP tax rates are expected to be approximately 20% to 25%. GAAP P&L results are expected to include the items below, totaling approximately $310 million to $340 million, as well as their related tax effects:approximately
More news about: PTC Inc.
Nov 05, 2025, 14:25 ET LaFleur Minerals Advances Swanson Confirmation Drilling to Support Beacon Mill Restart and PEA
industry; (b) market opportunity; (c) Lafleur Minerals Inc.'s business plans and strategies; (d) services that Lafleur Minerals Inc. intends to offer; (e) L Lafleur Minerals Inc.'s milestone projections and targets; (f) Lafleur Minerals Inc.'s expectations regarding receipt of approval for regulatory applications;
More news about: Lafleur Minerals Inc.
Nov 05, 2025, 13:38 ET IISc Foundation and IndusSetu Forge Global Partnership to Advance Medical Education, Research, and Equitable Healthcare
Priya Tandon Founder & CEO, USA | [email protected] and Tiara Kar Nanda, Chief Coordinator l [email protected]
More news about: IISc Foundation
Nov 05, 2025, 13:34 ET Iorio Law PLLC Files Nearly $2 Million FINRA Arbitration Claim Over Sale of GWG L Bonds; DOJ Indictment of Former GWG CEO Underscores Investor Concerns
GWG L Bond Investor Recovery Center for more information about their rights. Background on GWG L Bonds GWG Holdings, Inc., based in Dallas, raised nearly $2 billion from retail investors through its L Bond
More news about: Iorio Law PLLC
Nov 05, 2025, 13:24 ET Finatical Software Unveils Powerful New Excel Reporting Enhancements for QuickBooks Online Users
I use this app for all of my clients. I can update my finance committee, leadership, and board reports by changing one date in Excel, and then my P&L and Balance Sheet reports are updated to that date... I probably saved at least 10 hours for each client, each report cycle. AMAZING."
More news about: Finatical Software
Nov 05, 2025, 12:04 ET TrewUp Recognized as a 2025 Inc. Power Partner Award Winner
their trade spend and grow with confidence," said Kyle Barnholt, CEO and co-founder of TrewUp. "We know trade is one of the largest lines on the P&L—and one of the least understood. TrewUp was built to bring clarity where there's usually chaos, and to be the kind of partner who's as invested in our
More news about: TrewUp LLC
Nov 05, 2025, 11:36 ET Sobi to present New One-Year Data on pegcetacoplan's efficacy in C3G and primary IC-MPGN and new outcome data on NASP at ASN Kidney Week
1. Smith RJH, et al. Nat Rev Nephrol. 2019;15(3):129-143. 2. Servais A, et al. Kidney Int. 2012;82(4):454-464. 3. Zand L, et al. J Am Soc Nephrol. 2014;25(5):1110-1117. 4. Tarragón, B, et al. C3 Glomerulopathy Recurs Early after Kidney Transplantation in Serial
More news about: Swedish Orphan Biovitrum AB
Nov 05, 2025, 10:57 ET Late-Breaking Clinical Trial Results Announced at VIVA 2025
At 48 hours, less tachycardia and lower oxygen requirements were present in the CAVT arm vs the AC arm (2.2% vs 20.8%; P =.005 and 0.5 L/min vs 1.4 L/min; P =.027, respectively). Patients in the CAVT arm had a greater improvement in PVFS scores at discharge compared to the AC arm (P =.022).
More news about: The VIVA Foundation
Nov 05, 2025, 10:41 ET INTERNATIONAL AIRPORT FINANCE, S.A. ANNOUNCES SUCCESSFUL RESULTS OF CONSENT SOLICITATION RELATED TO THE 12.000% SENIOR SECURED NOTES DUE 2033
(CUSIP Nos. 45900T AA0 / E6R69L AA2; ISIN Nos. US45900TAA07 / USE6R69LAA27) MADRID, Nov. 5, 2025 /PRNewswire/ -- International Airport Finance,
More news about: International Airport Finance, S.A.
Nov 05, 2025, 10:00 ET Injective Launches iBuild: The First No‑Code AI Platform for Web3 App Developers
Injective is the interoperable layer one (L1) blockchain operating at the intersection of DeFi and TradFi. Its ecosystem offers a full suite of products for developers and end-users,
More news about: Injective
Nov 05, 2025, 09:58 ET Apuntes de Una Vida: Memorias del excongresista Lincoln Díaz-Balart
promueve los principios democráticos de La Rosa Blanca, primera organización creada para luchar contra la dictadura de Castro, fundada por su padre, Rafael L. Díaz-Balart, en Nueva York el 28 de enero de 1959. "Agradezco haber podido trabajar en estas memorias con mi padre y me entusiasma
More news about: The Congressional Hispanic Leadership Institute
Nov 05, 2025, 09:58 ET Apuntes de Una Vida: Memorias del excongresista Lincoln Díaz-Balart
promueve los principios democráticos de La Rosa Blanca, primera organización creada para luchar contra la dictadura de Castro, fundada por su padre, Rafael L. Díaz-Balart, en Nueva York el 28 de enero de 1959. "Agradezco haber podido trabajar en estas memorias con mi padre y me entusiasma
More news about: The Congressional Hispanic Leadership Institute
Nov 05, 2025, 09:22 ET Lunai Bioworks achieves complete regression of both primary and metastatic pancreatic tumors in preclinical humanized models, marking a breakthrough in allogeneic cancer immunotherapy
doi:10.3390/vaccines13070749), which first demonstrated potent anti-tumor activity of CD34+ hematopoietic stem cell (HSC)-derived DCs engineered to overexpress CD40L, CD93, and CXCL13 in humanized mouse models of pancreatic cancer. While the initial study utilized a research-grade lentiviral vector, the latest report
More news about: Lunai Bioworks Inc.
Nov 05, 2025, 09:14 ET HIDDEN VALLEY RANCH® TURNS TINY NYC APARTMENT INTO THE ULTIMATE POP-UP RESTAURANT EXPERIENCE
instagram.com/hidden.valleyFollow us on TikTok: tiktok.com/@hiddenvalleyranchLearn more at HiddenValley.com *Based on IRI unit sales data for L52WE 6/29/25. Contact:Kelly Thackery [email protected]
More news about: Hidden Valley Ranch
Nov 05, 2025, 09:00 ET Fziomed Initiates Commercialization of Oxiplex Gel in the United States
"Having Oxiplex available in the U.S. provides spine surgeons with a new, evidence-based tool to address a significant unmet clinical need," said Alfred L. Rhyne, MD, orthopedic surgeon specializing in the diagnosis and treatment of spine conditions at OrthoCarolina (Charlotte, NC). "Patients will now benefit
More news about: Fziomed, Inc.
Nov 05, 2025, 09:00 ET MarginEdge Named an Inc. 2025 Power Partner for Helping Restaurants Run Smarter
exceptional hospitality. Today, more than 10,000 restaurants across the U.S. and Canada use the platform to automate invoice processing, track daily P&L, and gain predictive insights into purchasing and profitability. With a customer satisfaction rating of just over 95%, MarginEdge embodies the kind
More news about: MarginEdge
Nov 05, 2025, 08:57 ET CREModels Launches GL-Based Real Estate Portfolio-Analysis Tool
Director. "Alternately, they might use presentation platforms to share files that they themselves have painstakingly created, or just repackage the P&L statement for different audiences. There's no real analytics engine to speak of." The CRE Suite automatically pulls in thousands
More news about: CREModels
Nov 05, 2025, 08:30 ET Sketches from A Life: Memoir by Former Congressman Lincoln Díaz-Balart Now Available
The White Rose Institute, which promotes the democratic principles of The White Rose, the first anti-Castro organization, founded by his father, Rafael L. Díaz-Balart, in New York on January 28, 1959. "I am grateful to have been able to work on this memoir with my father, and
More news about: The Congressional Hispanic Leadership Institute
Nov 05, 2025, 08:30 ET Parker Institute for Cancer Immunotherapy Demonstrates Leadership and Showcases Latest Advances in Immunotherapy at SITC 2025 Annual Meeting
Abstract 1126, Poster Presentation, Saturday, November 8)Co-authors: PICI Investigators Crystal L. Mackall, MD (Stanford Medicine); David Miklos, MD, PhD (Stanford Medicine); Zinaida Good, PhD (Stanford Medicine)
More news about: Parker Institute for Cancer Immunotherapy